Published in Neuropsychopharmacology on August 01, 1999
Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav (2009) 1.37
Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harv Rev Psychiatry (2009) 1.19
The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci Biobehav Rev (2010) 1.16
Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice. Psychopharmacology (Berl) (2012) 1.10
Acquisition of cocaine self-administration in ovariectomized female rats: effect of estradiol dose or chronic estradiol administration. Drug Alcohol Depend (2007) 1.10
Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol Biochem Behav (2006) 1.09
Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats. Pharmacol Biochem Behav (2008) 1.07
Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology (2011) 1.06
Gender differences in zebrafish responses to cocaine withdrawal. Physiol Behav (2008) 1.06
Estradiol: a key biological substrate mediating the response to cocaine in female rats. Horm Behav (2009) 1.02
Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys. Exp Clin Psychopharmacol (2010) 0.99
Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase. Neuropsychopharmacology (2011) 0.98
The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav (2010) 0.97
Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys. Neuropsychopharmacology (2011) 0.96
Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacol Biochem Behav (2007) 0.93
The effects of exogenous progesterone on drug craving and stress arousal in cocaine dependence: impact of gender and cue type. Psychoneuroendocrinology (2013) 0.91
Differential effects of allopregnanolone on the escalation of cocaine self-administration and sucrose intake in female rats. Psychopharmacology (Berl) (2010) 0.89
Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Drug Alcohol Depend (2011) 0.87
Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates. Pharmacol Biochem Behav (2007) 0.86
Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy. Neuropharmacology (2012) 0.85
Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 0.85
Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys. J Pharmacol Exp Ther (2012) 0.83
Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. Neuropsychopharmacology (2005) 0.82
Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progestogen levels among intact rats. Horm Behav (2010) 0.80
The circadian system is a target and modulator of prenatal cocaine effects. PLoS One (2007) 0.80
Ovarian hormones and drug abuse. Curr Psychiatry Rep (2014) 0.80
Sex differences in the subjective effects of oral Δ(9)-THC in cannabis users. Pharmacol Biochem Behav (2016) 0.79
PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations. Neuropharmacology (2013) 0.79
Increased impulsive choice for saccharin during PCP withdrawal in female monkeys: influence of menstrual cycle phase. Psychopharmacology (Berl) (2013) 0.79
Effects of menstrual cycle phase on the reinforcing effects of phencyclidine (PCP) in rhesus monkeys. Pharmacol Biochem Behav (2006) 0.79
Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway. Psychopharmacology (Berl) (2008) 0.79
Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques. Horm Behav (2012) 0.79
Sex and menstrual cycle effects on chronic oral cocaine self-administration in rhesus monkeys: Effects of a nondrug alternative reward. Psychopharmacology (Berl) (2016) 0.76
Testosterone is essential for cocaine sensitization in male rats. Physiol Behav (2010) 0.76
Sex effects in cocaine-using methadone patients randomized to contingency management interventions. Exp Clin Psychopharmacol (2015) 0.75
Antiandrogen pretreatment alters cocaine pharmacokinetics in men. J Addict Med (2007) 0.75
Factors Determining Conjugation in Paramecium Aurelia II. Genetic Diversities between Stocks or Races. Genetics (1936) 3.54
Behavioral studies of sleep patterns in alcoholics during intoxication and withdrawal. J Pharmacol Exp Ther (1970) 2.45
Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry (1998) 2.26
Management of cocaine abuse and dependence. N Engl J Med (1996) 2.24
Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology (1997) 2.21
Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07
An algorithm for secondary structure determination in proteins based on sequence similarity. FEBS Lett (1986) 2.01
Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry (2005) 1.95
Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry (1989) 1.94
Exercise-related hematuria. Findings in a group of marathon runners. JAMA (1979) 1.86
Secondary structure prediction: combination of three different methods. Protein Eng (1988) 1.80
Segregation of transcription and replication sites into higher order domains. Science (1998) 1.76
The effects of type 1 diabetes on cerebral white matter. Diabetologia (2007) 1.74
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry (2000) 1.66
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry (1988) 1.64
Adrenal function and alcoholism. I. Serum cortisol. Psychosom Med (1971) 1.62
Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry (2000) 1.60
Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther (1997) 1.52
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (2006) 1.50
Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am J Neuroradiol (1993) 1.48
Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther (1982) 1.46
Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA (1996) 1.44
Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. J Nucl Med (1995) 1.43
Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med (2010) 1.43
Severe adverse interaction between pethidine and selegiline. Lancet (1991) 1.42
Preliminary Observations on the Epidemiology of Mental Disease. Am J Public Health Nations Health (1939) 1.40
Association of chromosome territories with the nuclear matrix. Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins. J Cell Biol (1999) 1.40
A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix. J Cell Sci (1991) 1.39
Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry (1988) 1.38
Centralized Collection of Marriage and Divorce Records and Their Uses. Am J Public Health Nations Health (1941) 1.37
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA (1994) 1.36
Elevated creatine kinase MB isoenzyme levels in marathon runners. Normal myocardial scintigrams suggest noncardiac source. JAMA (1981) 1.36
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence. J Med Chem (2000) 1.35
Survival following first diagnosis of coronary heart disease. Am Heart J (1969) 1.35
Age-related reduction in functional MRI response to photic stimulation. Neurology (1997) 1.34
Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res (1998) 1.32
Behavioral toxicology: a developing discipline. Fed Proc (1975) 1.32
Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther (1998) 1.31
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A (1992) 1.30
Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology (1993) 1.30
Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry (1996) 1.29
Influence of baseline hematocrit and hemodilution on BOLD fMRI activation. Magn Reson Imaging (2001) 1.29
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry (2000) 1.28
Targeting of PCNA to sites of DNA replication in the mammalian cell nucleus. J Cell Biochem (2001) 1.28
Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med (2000) 1.28
Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients. J Clin Pharmacol J New Drugs (1970) 1.27
Functional magnetic resonance imaging of facial affect recognition in children and adolescents. J Am Acad Child Adolesc Psychiatry (1999) 1.27
Buprenorphine suppresses heroin use by heroin addicts. Science (1980) 1.27
Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther (1999) 1.25
Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA (1998) 1.23
Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol (1998) 1.21
Elevated skeletal muscle creatine kinase MB isoenzyme levels in marathon runners. JAMA (1983) 1.18
Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord (2000) 1.18
Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther (1981) 1.17
Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) (1999) 1.17
Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry (2000) 1.16
Cigarette smoking by women: interactions with alcohol use. Psychopharmacology (Berl) (1987) 1.16
The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry (1983) 1.13
Experimentally induced intoxication in alcoholics: a comparison between programed and spontaneous drinking. J Pharmacol Exp Ther (1970) 1.11
Interhemispheric transfer of a discrimination of moving patterns in pigeon. Brain Res (1968) 1.11
Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther (2001) 1.11
Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther (1999) 1.11
Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry (1997) 1.10
On the nature of dilute aqueous cholesterol suspensions. J Lipid Res (1983) 1.10
Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am J Psychiatry (2001) 1.10
Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry (2000) 1.10
Antidepressant-related akathisia. J Clin Psychopharmacol (1987) 1.09
The "Cloret sign". N Engl J Med (1978) 1.08
The protein structure code: what is its present status? Comput Appl Biosci (1991) 1.08
"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry (1980) 1.08
Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry (2000) 1.08
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. Bioorg Med Chem Lett (2001) 1.06
Effects of heroin self-administration on cigarette smoking. Psychopharmacology (Berl) (1980) 1.06
Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology (1998) 1.06
Skeletal muscle injury and repair in marathon runners after competition. Am J Pathol (1985) 1.06
Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. J Pharmacol Exp Ther (1977) 1.05
Ferromagnetic contrast agents: a new approach. Magn Reson Med (1986) 1.05
Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl) (2000) 1.05
Buprenorphine effects on cigarette smoking. Psychopharmacology (Berl) (1985) 1.04
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther (2009) 1.03
Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis. Technol Health Care (1998) 1.03
Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist. Am J Psychiatry (1997) 1.03
Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. J Rheumatol (1988) 1.02
Adrenal function and alcoholism. II. Catecholamines. Psychosom Med (1971) 1.02
Experimental analysis of drinking behavior of chronic alcoholics. Ann N Y Acad Sci (1966) 1.01